XM does not provide services to residents of the United States of America.

S&P 500, Nasdaq climb; markets analyze Trump's tariff threats, Fed minutes



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>US STOCKS-S&P 500, Nasdaq climb; markets analyze Trump's tariff threats, Fed minutes</title></head><body>

Ford, GM fall after tariff threats

Best Buy drops after trimming annual sales, profit forecast

Amgen falls as keenly awaited obesity drug data disappoints

Wells Fargo up on report of likely lifting of asset cap 2025

Indexes: Dow flat, S&P 500 up 0.41%, Nasdaq up 0.51%

Updates with mid-session trading

By Saeed Azhar, Johann M Cherian and Purvi Agarwal

Nov 26 (Reuters) -The benchmark S&P 500 and the Nasdaq extended recent gains on Tuesday, as technology stocks rebounded, while investors digested President-elect Donald Trump's tariff pledges on top trade partners and the latest minutes from the Federal Reserve.

U.S. short-term interest-rate futures pared earlier losses after the Fed's latest minutes showed officials appeared divided over how much further they may need to cut interest rates.

The minutes of the Nov. 6-7 meeting also showed the group agreed this was a moment to avoid giving much concrete guidance about how U.S. monetary policy is likely to evolve in the weeks ahead.

Trump said he would impose a 25% conditional tariff on Canadian and Mexican imports that could violate a free-trade deal he negotiated during his previous term. He also outlined "an additional 10% tariff, above any additional tariffs" on imports from China, raising the risk of trade wars.

Automakers Ford F.N and General Motors GM.N - which have highly integrated supply chains across Mexico, the U.S. and Canada - lost 2.2% and 8.3%, respectively.

"The concern is that some products are going to become more costly and that will mean revenue for those companies that are possibly manufacturing those goods overseas is going to decline," said Robert Pavlik, senior portfolio manager at Dakota Wealth.

"It's a lot of back-and-forth right now because investors are trying to position themselves for January and the days after and they're not really sure."

At 2:11 p.m. EST the Dow Jones Industrial Average .DJI fell 15.74 points, or 0.04%, to 44,720.83, the S&P 500 .SPX gained 24.38 points, or 0.41%, to 6,011.75 and the Nasdaq Composite .IXIC gained 96.90 points, or 0.51%, to 19,152.47.

Gains in megacaps such as Microsoft MSFT.O and Apple AAPL.O boosted the information technology sector .SPLRCT and the tech-heavy Nasdaq.

"Markets have become desensitized to tariffs as most believe the rhetoric to be more aggressive than the eventual tariffs themselves," said Jamie Cox, managing partner at Harris Financial Group

"It also doesn't hurt that the economy is showing up stronger lately, which helps to offset the fiscal drag of tariffs in the short run."

Well Fargo WFC.N stood out among sluggish banking stocks, gaining almost 1.3% after Reuters reported, citing sources, that the bank is in the last stages of a process to pass regulatory tests to lift a $1.95 trillion asset cap next year after fixing problems from its scandal over fake accounts.

The blue-chip Dow was weighed down by declines in Amgen AMGN.O, which slid 7.6% after its experimental obesity drug fell short of expectations.

The S&P 500 touched a record high on Monday and logged its sixth-straight session of gains, while the Russell 2000 .RUT also scaled an all-time high after three years. On the day, the small-cap index fell 0.6%.

Among others, Eli Lilly rose 5.1% after U.S. President Joe Biden was set to propose expanding Medicare and Medicaid coverage for anti-obesity drugs.

Best Buy BBY.N lost 5.7% and was among top decliners on the S&P 500 after trimming its annual profit and sales forecasts.

Declining issues outnumbered advancers by a 1.88-to-1 ratio on the NYSE. There were 231 new highs and 39 new lows on the NYSE.

The S&P 500 posted 45 new 52-week highs and 3 new lows while the Nasdaq Composite recorded 104 new highs and 85 new lows.



Reporting by Saeed Azhar in Toronto; Johann M Cherian and Purvi Agarwal in Bengaluru; Editing by Maju Samuel and Matthew Lewis

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.